These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16598555)

  • 21. Haplotypes in the lipoprotein lipase gene influence high-density lipoprotein cholesterol response to statin therapy and progression of atherosclerosis in coronary artery bypass grafts.
    Goodarzi MO; Taylor KD; Scheuner MT; Antoine HJ; Guo X; Shah PK; Rotter JI
    Pharmacogenomics J; 2007 Feb; 7(1):66-73. PubMed ID: 16755277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of coronary artery disease progression by cholesterol-lowering therapy: the angiographic studies.
    Archbold RA; Timmis AD
    Curr Opin Lipidol; 1999 Dec; 10(6):527-34. PubMed ID: 10680047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cholesterol lowering and cardiovascular risk factors on the progression of aortoiliac arteriosclerosis: a quantitative cineangiography study.
    Campeau L; Lespérance J; Bilodeau L; Fortier A; Guertin MC; Knatterud GL
    Angiology; 2005; 56(2):191-9. PubMed ID: 15793608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The role of cholesterol-lowering drugs in prevention of coronary heart disease].
    Skałuba Z; Undas R
    Przegl Lek; 1998; 55(7-8):382-7. PubMed ID: 10021881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual influenza immunization: as important as control of blood pressure and cholesterol as secondary prevention for cardiovascular disease.
    Grajewski J; Slusar M; Hayney MS
    J Am Pharm Assoc (2003); 2007; 47(5):662-3. PubMed ID: 17848356
    [No Abstract]   [Full Text] [Related]  

  • 26. LDL cholesterol: should guidelines include targets?
    Banerjee S; Kahali D; Banerjee A; Brilakis ES
    Expert Rev Cardiovasc Ther; 2014 Mar; 12(3):285-90. PubMed ID: 24502625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lowering cholesterol levels in patients with coronary heart disease. The LIPID Study Management Committee.
    Med J Aust; 1995 May; 162(9):455-6. PubMed ID: 7746199
    [No Abstract]   [Full Text] [Related]  

  • 30. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
    Rosenson R; Lloyd-Jones D;
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia.
    Kawasuji M; Sakakibara N; Fujii S; Yasuda T; Watanabe Y
    J Thorac Cardiovasc Surg; 2000 May; 119(5):1008-13; discussion 1013-4. PubMed ID: 10788822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK; White HD; Greaves SC
    N Z Med J; 1990 Feb; 103(883):41-3. PubMed ID: 2304688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?
    Deslypere JP
    Int J Clin Pract; 2000 Jun; 54(5):307-13. PubMed ID: 10954957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components.
    Virani SS
    Tex Heart Inst J; 2016 Aug; 43(4):313-4. PubMed ID: 27547139
    [No Abstract]   [Full Text] [Related]  

  • 35. A need to redefine the consensus on the use of statins in coronary heart disease prevention.
    Fruchart JC
    Eur Heart J; 2000 Oct; 21(19):1572-3. PubMed ID: 10988008
    [No Abstract]   [Full Text] [Related]  

  • 36. [New results in the management of hypercholesterolemia].
    Sármán B
    Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition and management of hypercholesterolaemia in patients awaiting elective coronary artery bypass grafting.
    Asimakopoulos G; Barlow C; Pillai R
    Postgrad Med J; 1998 Mar; 74(869):157-60. PubMed ID: 9640441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cholesterol and stroke risk: a role for statins?].
    Devuyst G; Bogousslavsky J
    Schweiz Med Wochenschr; 2000 Aug; 130(33):1157-63. PubMed ID: 11005106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversibility of atherosclerosis--evolving perspectives from two arterial imaging clinical trials: the cholesterol lowering atherosclerosis regression study and the monitored atherosclerosis regression study.
    Hodis HN
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S25-31. PubMed ID: 8907211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-lowering update 2001. Aggressive new goals.
    Fenske TK
    Can Fam Physician; 2001 Feb; 47():303-9. PubMed ID: 11228031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.